- Home
- AIMD vs CRIS Comparison
AIMD vs CRIS Comparison
Compare AIMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIMD
- CRIS
- Stock Information
- Founded
- AIMD 1984
- CRIS 2000
- Country
- AIMD United States
- CRIS United States
- Employees
- AIMD N/A
- CRIS N/A
- Industry
- AIMD Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIMD Health Care
- CRIS Health Care
- Exchange
- AIMD Nasdaq
- CRIS Nasdaq
- Market Cap
- AIMD 16.9M
- CRIS 15.9M
- IPO Year
- AIMD N/A
- CRIS 2000
- Fundamental
- Price
- AIMD $2.27
- CRIS $1.34
- Analyst Decision
- AIMD
- CRIS Strong Buy
- Analyst Count
- AIMD 0
- CRIS 2
- Target Price
- AIMD N/A
- CRIS $16.50
- AVG Volume (30 Days)
- AIMD 37.4K
- CRIS 81.6K
- Earning Date
- AIMD 11-13-2025
- CRIS 11-06-2025
- Dividend Yield
- AIMD N/A
- CRIS N/A
- EPS Growth
- AIMD N/A
- CRIS N/A
- EPS
- AIMD N/A
- CRIS N/A
- Revenue
- AIMD $113,037.00
- CRIS $11,650,000.00
- Revenue This Year
- AIMD N/A
- CRIS $2.72
- Revenue Next Year
- AIMD N/A
- CRIS $8.27
- P/E Ratio
- AIMD N/A
- CRIS N/A
- Revenue Growth
- AIMD 178.19
- CRIS 13.56
- 52 Week Low
- AIMD $2.00
- CRIS $1.02
- 52 Week High
- AIMD $5.00
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- AIMD 28.33
- CRIS 40.54
- Support Level
- AIMD $2.59
- CRIS $1.13
- Resistance Level
- AIMD $3.16
- CRIS $1.35
- Average True Range (ATR)
- AIMD 0.24
- CRIS 0.10
- MACD
- AIMD -0.11
- CRIS -0.02
- Stochastic Oscillator
- AIMD 0.00
- CRIS 40.22
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.